ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur DICYNONE® 500 capsules:OM Pharma SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
B02BX01 - EtamsylateATC-DDD Version 2016. Source: WHO
B - Blood and Blood Forming Organs
 
B02 - Antihemorrhagics
 
B02B - Vitamin K and Other Hemostatics
 

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).

B02BX - Other Systemic Hemostatics

This group comprises systemic hemostatics, which cannot be classified elsewhere.

The DDD for avatrombopag is based on the starting dose in the treatment of chronic immune thrombocytopenia.

B02BX01 - Etamsylate
2024 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home